Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BOEHRINGER SEEKS TO ENJOIN LIFESCAN FROM MAKING GLUCOSE MONITORS BASED ON ACCUTREND DM TECHNOLOGY; SUIT CHARGES J&J UNIT WITH INDUSTRIAL ESPIONAGE

This article was originally published in The Gray Sheet

Executive Summary

Boehringer Mannheim Corporation is seeking to enjoin Johnson & Johnson's LifeScan subsidiary from selling blood glucose monitors that incorporate technology from its Accutrend DM monitor. In a suit filed June 19 in the U.S. District Court in Indianapolis, Boehringer alleges that LifeScan illegally obtained information on the monitor through industrial espionage and should be barred "from marketing any products based on the information for a period of time equal to that it would have taken LifeScan and [J&J] to develop those products independently."
UsernamePublicRestriction

Register

MT006200

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel